Endo's microbicide gel fails to protect against HIV
This article was originally published in Scrip
Executive Summary
Endo Pharmaceuticals' microbicide vaginal gel, PRO 2000 (naphthalene sulfonate polymer), intended for the prevention of HIV infection,has failed to show efficacy in a Phase III study involving more than 9,000 African women.